Rosen & Barkin's 5-Minute Emergency Medicine Consult (101 page)

Read Rosen & Barkin's 5-Minute Emergency Medicine Consult Online

Authors: Jeffrey J. Schaider,Adam Z. Barkin,Roger M. Barkin,Philip Shayne,Richard E. Wolfe,Stephen R. Hayden,Peter Rosen

Tags: #Medical, #Emergency Medicine

BOOK: Rosen & Barkin's 5-Minute Emergency Medicine Consult
7.82Mb size Format: txt, pdf, ePub
DIFFERENTIAL DIAGNOSIS
  • Anthrax:
    • Influenza
    • Bacterial pneumonia, bacterial meningitis
    • Brown recluse spider bite
    • Tularemia
    • Streptococcal/staphylococcal skin infection
  • Plague:
    • Tularemia, catscratch disease
    • Lymphogranuloma venereum, chancroid
    • Tuberculosis
    • Streptococcal adenitis
    • Meningitis, encephalitis, sepsis
  • Smallpox:
    • Varicella
    • Rash starts centrally on trunk and spreads outward:
      • Lesions in different stages of development
      • Rarely involves palms or soles
      • Disseminated molluscum contagiosum
    • Monkeypox, drug eruptions
  • Toxins:
    • Staphylococcal enterotoxin B:
      • Most common cause of food poisoning
      • Can be aerosolized in addition to being placed in food or water reservoir
      • When inhaled, produces febrile type of illness that can progress to septic shock picture
    • Ricin:
      • Plant protein derived from castor beans
      • Causes rapid progression from upper respiratory congestion to cardiopulmonary collapse
      • Ingestion is less toxic because GI tract does not absorb it well, but it can lead to local cytotoxic death, shock, and death.
    • Botulinum toxin:
      • Initially symptoms include cranial nerve dysfunction with descending paralysis that leads to respiratory failure.
    • Mycotoxins:
      • Highly toxic compounds produced by certain species of fungus
      • Dermal, respiratory, or GI contact can rapidly lead to multiorgan system failure and death.
TREATMENT
PRE HOSPITAL

Universal precautions with N-95 mask

INITIAL STABILIZATION/THERAPY
  • ABCs
  • 0.9% NS fluid bolus for hypotension
  • Supplemental oxygen for hypoxemia
  • Vasopressors for persistent hypotension
  • Respiratory and contact isolation for suspected cases
ED TREATMENT/PROCEDURES
  • All treatments include:
    • Control fever with acetaminophen.
    • Initiate therapy for specific disease.
  • Anthrax:
    • Initiate antibiotics:
      • IV for inhalational or severe cutaneous
      • Antibiotic choice depends on susceptibility.
    • Antibiotic options:
      • Ciprofloxacin: 1st line
      • Doxycycline
      • Rifampin
      • Clindamycin
      • Vancomycin
  • Plague:
    • Antibiotics initiated within 24 hr minimizes mortality.
    • 1st-line agents: Streptomycin or gentamicin
    • Add chloramphenicol if signs of meningitis or unstable patient
    • Prophylaxis: Doxycycline or ciprofloxacin
  • Brucellosis:
    • Supportive therapy
    • Start doxycycline 100 mg PO BID for 6 wk with the addition of streptomycin 1 g per day IM for the 1st 2–3 wk or rifampin 900 mg per day for 6 wk.
  • Q fever:
    • Recovery occurs within 2 wk without treatment.
    • Doxycycline shortens duration of illness.
  • Smallpox:
    • Supportive therapy
    • Vaccine given within 4 days of initial exposure decreases chances of contracting smallpox or developing severe symptoms.
    • Vaccinate medical staff caring for patient.
    • Treat secondary bacterial infection.
  • Tularemia:
    • See “Tularemia.”
  • Hemorrhagic fevers:
    • See “Hemorrhagic Fever.”
MEDICATION
  • Chloramphenicol: 25 mg/kg IV q6h
  • Ciprofloxacin: 400 mg IV q12h or 500 mg PO BID (peds: 15 mg/kg BID PO)
  • Clindamycin: 900 mg IV q12h
  • Doxycycline: 100 mg (peds: ≥45 kg, 100 mg; if weight ≤45 kg, 2.2 mg/kg IV) PO/IV q12h
  • Gentamicin: 5 mg/kg IM or IV q24h (peds: 2.5 mg/kg IV/IM q8h)
  • Rifampin: 10 mg/kg IV not to exceed 600 mg/d
  • Streptomycin: 1 g (peds: 20–40 mg/kg) IM q12h
  • Vancomycin: 1 g IV q12h
FOLLOW-UP
DISPOSITION
Admission Criteria
  • Decision to treat patient as inpatient vs. outpatient will have to be made in context of overall disaster.
  • Toxic or hypoxic patients require admission.
  • Respiratory isolation
Discharge Criteria

Mild, noncontagious illness

Issues for Referral
  • Contact local and state health departments for suspected or confirmed illness related to biologic weapons.
  • Infectious disease and toxicology consult for suspected illness
FOLLOW-UP RECOMMENDATIONS
  • Postexposure prophylaxis and vaccinations should be continued based on the causative agent.
  • Exposed staff should have follow-up with employee health and infection control prior to returning to work.
PEARLS AND PITFALLS
  • Early diagnosis is difficult, and a high index of suspicion is required.
  • Failing to use personal protective equipment to protect self and staff is a pitfall.
  • Suspect biologic weapons etiology when there is geographic clustering of patients who live, work, or attended an event in close proximity.
  • Initiate therapy or prophylaxis early in suspected illness.
ADDITIONAL READING
  • Centers for Disease Control and Prevention (CDC). Recognition of illness associated with the intentional release of a biologic agent.
    MMWR Morb Mortal Wkly Rep.
    2001;50:893–897.
  • Franz DR, Jahrling PB, Friedlander AM, et al. Clinical recognition and management of patients exposed to biological warfare agents.
    JAMA
    . 1997;278(5):399–411.
  • US Army Medical Research Institute of Infectious Diseases.
    Medical Management of Biological Casualties Handbook
    . 6th ed. Fort Detrick, Frederick, MD, April 2005.
Useful Websites
See Also (Topic, Algorithm, Electronic Media Element)
  • Botulism
  • Hemorrhagic Fever
  • Tularemia
CODES
ICD9
  • V01.0 Contact with or exposure to cholera
  • V71.82 Observation and evaluation for suspected exposure to anthrax
  • V71.83 Observation and evaluation for suspected exposure to other biological agent
ICD10
  • Z03.818 Encounter for observation for suspected exposure to other biological agents ruled out
  • Z20.09 Contact with and (suspected) exposure to other intestinal infectious diseases
  • Z20.810 Contact with and (suspected) exposure to anthrax
BIPOLAR DISORDER
Paul H. Desan

Gary S. Sachs
BASICS
DESCRIPTION
  • Mania:
    • Presentation is diverse and may be difficult to recognize as mania:
      • Simple irritability
      • Cheerfulness
      • Psychosis
      • Delirium
      • Agitation
    • Full extent of pathology often revealed only by outside informants
    • Onset gradual or acute, duration several weeks or months; rarely may be chronic
  • Hypomania:
    • Milder symptoms without marked impairment
  • Mixed mood:
    • Simultaneous symptoms of mania and depression
    • Treat in ED as for mania
  • Bipolar disorder:
    • Formerly manic depressive disorder
    • Defined as one or more episodes of hypomanic, manic, or mixed mood
    • Possibly with episodes of depressed mood
    • Bipolar II is used to denote cases where hypomania has occurred in the course of the disorder but never mania.
    • Typically begins in the teens or 20s
    • Episodes of abnormal mood may be mild or severe, brief or prolonged, infrequent or chronic, chiefly elevated or chiefly depressed in character.
    • Bipolar disorder may be readily responsive to treatment or nearly intractable.
  • Schizoaffective disorder:
    • Characterized by episodes of altered mood, but psychotic features present even when mood is normal

Other books

Deathly Contagious by Emily Goodwin
Amoeba (The Experiments) by Druga, Jacqueline
Wildfire Gospel (Habitat) by Wright, Kenya
Her Ladyship's Girl by Anwyn Moyle
Seer of Egypt by Pauline Gedge
Gaudi Afternoon by Barbara Wilson
Undue Influence by Anita Brookner